Loading...
Loading...
Morgan Stanley raises its price target on Overweight-rated Emerson Electric
EMR to $58 from $56 on the heels of the company's investor day.
Morgan Stanley says, "We believe there were several important positives: 1) EMR expects 2012/15 organic growth of 5-7%, consistent with its mid-cycle norms... 2) EMR did a good job of isolating Network Power problems to its $1.7bn Embedded Computing and Power businesses, which represent just 7% of sales but are probably losing $80-90m on a run-rate basis. ...3) EMR provided the perfect response to
concerns it is vulnerable to Chinese competition by offering the most thorough expose of the competitive landscape in China we have seen, along with detailed plans to attack the mid-tier segment of its markets."
EMR closed at $51.62 a share on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in